Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients

Clinical trial NCT06538038 · RECRUITING

Trial details

NCT number: NCT06538038
Sponsor: PrECOG, LLC.
Status: RECRUITING
Study type: OBSERVATIONAL

Non Small Cell Lung Cancer Epidermal Growth Factor Receptor Gene Mutation Stage III Lung Cancer Stage IV Lung Cancer

Start date: 2024-09-17
Primary completion: 2028-08-01
Enrollment: 538

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.